Management of Complicated Urinary Tract Infection in Male Patients with Urinary Calculus

Clinical Classification

Male gender automatically classifies a urinary tract infection as complicated, regardless of other factors【1】【3】.
Presence of a urinary stone creates anatomical obstruction, a defining feature of complicated UTI (cUTI)【1】【3】.
Renal colic signals active stone migration and a high risk of rapid progression to urosepsis if not promptly addressed【3】.

First‑line regimens:
- Amoxicillin + aminoglycoside (gentamicin 5 mg/kg once daily or amikacin 15 mg/kg once daily)【4】.
- Third‑generation cephalosporin (ceftriaxone 1–2 g once daily or cefotaxime 2 g three times daily)【4】.
Rationale for ceftriaxone as the primary choice:
- Achieves excellent urinary concentrations with convenient once‑daily dosing【5】【4】【3】.
- Provides reliable coverage of the most common uropathogens in stone disease—E. coli (≈32‑36 % of isolates), Proteus spp., Klebsiella spp., and other Enterobacteriaceae【1】.

Piperacillin‑tazobactam 2.5–4.5 g three times daily – resistance rates in stone patients are ≈7 % for E. coli and 16 % for Proteus spp.【5】【4】.
Aminoglycosides (gentamicin or amikacin) – amikacin shows low resistance (≈3.6 % for E. coli, 7.4 % for Proteus spp.) and should be combined with amoxicillin for synergistic effect【5】【4】【2】.

Fluoroquinolones (ciprofloxacin, levofloxacin) are discouraged when the patient has used a fluoroquinolone within the past 6 months【3】.
Semisynthetic penicillins (resistance >50 %), cefuroxime (resistance >60 %), and trimethoprim‑sulfamethoxazole (high resistance) should not be used as first‑line empiric therapy【1】.

Total therapy of 7–14 days based on clinical response【6】【2】.
14 days is recommended for male patients when prostatitis cannot be excluded【6】【2】.
Course may be shortened to 7 days if the patient is hemodynamically stable and afebrile for ≥48 hours【6】【2】.

Obtain urine culture and susceptibility testing before initiating antibiotics; adjust therapy according to results【1】【6】【2】.
Address the obstructive stone promptly: perform imaging to assess obstruction【7】 and consider urgent drainage when infection coexists with obstruction.

Switch to oral agents once the patient is clinically stable (afebrile ≥48 h, improving symptoms):
- Ciprofloxacin 500–750 mg twice daily if the isolate is susceptible and local resistance <10 %【4】.
- Levofloxacin 750 mg once daily if susceptible【4】.
- Trimethoprim‑sulfamethoxazole 160/800 mg twice daily if susceptible【6】.

In the presence of any of the following, consider carbapenems (meropenem 1 g three times daily or imipenem‑cilastatin 0.5 g three times daily):
- Healthcare‑associated infection【7】.
- Recent exposure to antibiotics【7】.
- Known ESBL‑producing pathogens【7】.
- Immunosuppression【7】.

Vigilantly watch for: fever/rigors, altered mental status, hypotension (systolic BP < 100 mmHg), and respiratory rate > 22/min【7】.

Failing to recognize that male gender alone makes the infection complicated, necessitating broader antimicrobial coverage and a longer treatment duration than uncomplicated cystitis【1】【3】.